Mark Froimson - Net Worth and Insider Trading
Mark Froimson Net Worth
The estimated net worth of Mark Froimson is at least $206,674 dollars as of 2024-09-24. Mark Froimson is the Director of Pacira BioSciences Inc and owns about 14,473 shares of Pacira BioSciences Inc (PCRX) stock worth over $206,674. Details can be seen in Mark Froimson's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark Froimson has not made any transactions after 2024-08-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mark Froimson
Mark Froimson Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark Froimson owns 1 companies in total, including Pacira BioSciences Inc (PCRX) .
Click here to see the complete history of Mark Froimson’s form 4 insider trades.
Insider Ownership Summary of Mark Froimson
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PCRX | Pacira BioSciences Inc | 2024-08-12 | director |
Mark Froimson Latest Holdings Summary
Mark Froimson currently owns a total of 1 stock. Mark Froimson owns 14,473 shares of Pacira BioSciences Inc (PCRX) as of August 12, 2024, with a value of $206,674.
Latest Holdings of Mark Froimson
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PCRX | Pacira BioSciences Inc | 2024-08-12 | 14,473 | 14.28 | 206,674 |
Holding Weightings of Mark Froimson
Mark Froimson Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark Froimson has made a total of 3 transactions in Pacira BioSciences Inc (PCRX) over the past 5 years, including 1 buys and 2 sells. The most-recent trade in Pacira BioSciences Inc is the acquisition of 1,400 shares on August 12, 2024, which cost Mark Froimson around $16,212.
Insider Trading History of Mark Froimson
- 1
Mark Froimson Trading Performance
GuruFocus tracks the stock performance after each of Mark Froimson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark Froimson is 11.72%. GuruFocus also compares Mark Froimson's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark Froimson within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mark Froimson's insider trading performs compared to the benchmark.
Performance of Mark Froimson
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 3.4 | | | | | |
| Relative Return to S&P 500(%) | 1.71 | | | | | |
Mark Froimson Ownership Network
Mark Froimson Owned Company Details
What does Pacira BioSciences Inc do?
Who are the key executives at Pacira BioSciences Inc?
Mark Froimson is the director of Pacira BioSciences Inc. Other key executives at Pacira BioSciences Inc include Chief Operating Officer Daryl Gaugler , Chief Clinical Officer Jonathan Slonin , and CAO and General Counsel Kristen Marie Williams .
Pacira BioSciences Inc (PCRX) Insider Trades Summary
Over the past 18 months, Mark Froimson made no insider transaction in Pacira BioSciences Inc (PCRX). Other recent insider transactions involving Pacira BioSciences Inc (PCRX) include a net sale of 12,186 shares made by Lauren Bullaro Riker , a net sale of 9,754 shares made by Jonathan Slonin , and a net sale of 7,052 shares made by Daryl Gaugler .
In summary, during the past 3 months, insiders sold 4,281 shares of Pacira BioSciences Inc (PCRX) in total and bought 20,976 shares, with a net purchase of 16,695 shares. During the past 18 months, 231,391 shares of Pacira BioSciences Inc (PCRX) were sold and 20,976 shares were bought by its insiders, resulting in a net sale of 210,415 shares.
Pacira BioSciences Inc (PCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Pacira BioSciences Inc Insider Transactions
Mark Froimson Mailing Address
Above is the net worth, insider trading, and ownership report for Mark Froimson. You might contact Mark Froimson via mailing address: 5 Sylvan Way, Suite 300, Parsippany Nj 07054.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
